✦ LIBER ✦

Mutational Profile and Prognostic Significance of TP53 in Diffuse Large B-cell Lymphoma Patients Treated with Rituximab-CHOP: A Report From an International DLBCL Rituximab-CHOP Consortium Program Study

✍ Scribed by Xu-Monette, Zijun Y.; Wu, Lin; Visco, Carlo; Tai, Yu Chuan; Tzankov, Alexander; Liu, Wei-min; Montes-Moreno, Santiago; Dybkær, Karen; Chiu, April; Orazi, Attilio; Zu, Youli; Bhagat, Govind; Richards, Kristy L.; Hsi, Eric D.; Zhao, X. Frank; Choi, William W.L.; Zhao, Xiaoying; van Krieken, J. Han; Huang, Qin; Huh, Jooryung; Ai, Weiyun; Ponzoni, Maurilio; Ferreri, Andrés J.M.; Zhou, Fan; Kahl, Brad S.; Winter, Jane N.; Xu, Wei; Li, Jianyong; Go, Ronald S.; Li, Yong; Piris, Miguel A.; Møller, Michael B.; Miranda, Roberto N.; Abruzzo, Lynne V.; Medeiros, L. Jeffrey; Young, Ken H.

Book ID: 122254984
Publisher: Elsevier
Year: 2013
Tongue: English
Weight: 64 KB
Volume: 13
Category: Article
ISSN: 2152-2650
DOI: 10.1016/j.clml.2013.07.094

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prognostic Significance of Survivin and

Prognostic Significance of Survivin and Caspase-3 Immunohistochemical Expression in Patients with Diffuse Large B-cell Lymphoma Treated with Rituximab and CHOP

✍ Zdravko Mitrović; Ivana Ilić; Igor Aurer; Sandra Bašić Kinda; Ivo Radman; Snježa 📂 Article 📅 2010 🏛 Springer Netherlands 🌐 English ⚖ 308 KB

Comprehensive gene expression profiling

Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study

✍ Visco, C; Li, Y; Xu-Monette, Z Y; Miranda, R N; Green, T M; Li, Y; Tzankov, A; W 📂 Article 📅 2012 🏛 Nature Publishing Group 🌐 English ⚖ 776 KB

Comprehensive gene expression profiling

✍ Visco, C; Li, Y; Xu-Monette, Z Y; Miranda, R N; Green, T M; Li, Y; Tzankov, A; W 📂 Article 📅 2014 🏛 Nature Publishing Group 🌐 English ⚖ 65 KB

CD30 expression defines a novel subgroup

CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study

✍ Hu, S.; Xu-Monette, Z. Y.; Balasubramanyam, A.; Manyam, G. C.; Visco, C.; Tzanko 📂 Article 📅 2013 🏛 American Society of Hematology 🌐 English ⚖ 888 KB

Prognostic relevance of pretreatment qua

Prognostic relevance of pretreatment quality of life in diffuse large B-cell lymphoma patients treated with rituximab-CHOP: Results from a prospective cohort study

✍ Hyun Ae Jung, Silvia Park, Jin Hyun Cho, Seonwoo Kim, Young Hyeh Ko… 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 397 KB

Lack of prognostic significance of the g

Lack of prognostic significance of the germinal-center phenotype in diffuse large B-cell lymphoma patients treated with CHOP-like chemotherapy with and without rituximab

✍ Ivana Ilić; Zdravko Mitrović; Igor Aurer; Sandra Bašić-Kinda; Ivo Radman; Radmil 📂 Article 📅 2009 🏛 Carden Jennings Publishing 🌐 English ⚖ 268 KB